Abstract
Purpose
The Dutch national guideline for Cardiovascular Risk Management advised in 2006 initiation of statin therapy in new patients with simvastatin. After the introduction of this guideline several measures were taken to increase the prescription of simvastatin in general practice. The aim of this paper is to describe the trend and interpractice variation in the relative share of simvastatin in statin prescription over a 7-year period (2003–2009) in Dutch general practices.
Methods
Data were used from the National Registration Network of General Practice (LINH) in the Netherlands. We used multilevel logistic regression analysis with individuals nested within practices. We evaluated the variance at different time points by the intra-class correlation (ICC).
Results
The share of simvastatin prescriptions of all statin prescriptions increased from 40% in 2003 to 82% in 2009. While the ICC was above 20% during the periods 2005 to 2007, it decreased rapidly from 25% in 2007 to only 9% in 2009.
Conclusion
Our results indicate that a combination of several intervention measures seems to have been successful. While it seems like the implementation of the guidelines alone had some effect, there was an additional effect when reimbursement measures were implemented. Furthermore, the practice seemed to have affected the adoption of the national CVRM guideline as the variation initially increased after the guideline implementation. By including information on both the proportion of simvastatin prescribed and interpractice variation, we achieved a more complete evaluation of how simvastatin prescription developed over time and how it was related to the different measures taken.
Similar content being viewed by others
References
Walley T, Folino-Gallo P, Stephens P, Van Ganse E (2005) Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003. Br J Clin Pharmacol 60(5):543–551
Mann D, Reynolds K, Smith D, Muntner P (2008) Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother 42(9):1208–1215
Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326(7404):1423
Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK (2006) Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med 166(21):2307–2313
Evaluation of the effects of statins (with particular consideration of atorvastatin). Cologne: Institut fur Qualität und Wirtschaftlichkeit im Gesundheitswesen; 2006
Devold HM, Molden E, Skurtveit S, Furu K (2009) Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy. Br J Clin Pharmacol 67(2):234–241
Sakshaug S, Furu K, Karlstad O, Ronning M, Skurtveit S (2007) Switching statins in Norway after new reimbursement policy: a nationwide prescription study. Br J Clin Pharmacol 64(4):476–481
Martikainen JE, Saastamoinen LK, Korhonen MJ, Enlund H, Helin-Salmivaara A (2010) Impact of restricted reimbursement on the use of statins in Finland: a register-based study. Med Care 48(9):761–766
Ohlsson H, Lindblad U, Lithman T, Ericsson B, Gerdtham UG, Melander A et al (2005) Understanding adherence to official guidelines on statin prescribing in primary health care—a multi-level methodological approach. Eur J Clin Pharmacol 61(9):657–665
NHG/CBO. Cardiovasculair risicomanagement, Multidisciplinaire richtlijn. Utrecht; 2006
Van Dijk L, De Bakker D (2002) Professionalization of Dutch PRGs and volume and costs of frequently prescribed drugs. Zeitschr Gesundheitsw 4:292–304
Vervloet M, Brabers AEM, Pisters MF, van Dijk L (2010) Evaluatie van het Programma Doelmatigheid Cardiovasculair Risicomanagement (CVRM). Utrecht
De Jong JD, Groenewegen PP, Spreeuwenberg P, Schellevis F, Westert GP (2010) Do guidelines create uniformity in medical practice? Soc Sci Med 70(2):209–216
Ohlsson H, Merlo J (2007) Understanding the effects of a decentralized budget on physicians’ compliance with guidelines for statin prescription; a multilevel methodological approach. BMC Health Serv Res 7:68
Merlo J, Ohlsson H, Lynch KF, Chaix B, Subramanian SV (2009) Individual and collective bodies: using measures of variance and association in contextual epidemiology. J Epidemiol Community Health 63(12):1043–1048
Verheij R, Van Dijk C, Abrahamse H, Davids R, Van den Hoogen H, Braspenning J et al (2010) Landelijk Informatienetwerk Huisartsenzorg. NIVEL/WOK, Feiten en cijfers over huisartsenzorg in Nederland. Utrecht/Nijmegen
Merlo J (2003) Multilevel analytical approaches in social epidemiology: measures of health variation compared with traditional measures of association. J Epidemiol Community Health 57(8):550–552
Rasbash J, Steele F, Browne W. A User's Guide to MLwiN, Version 2.0. Documentation Version 2.1e. London, UK: Centre for Multilevel Modelling, Institute of Education, University of London 2003
Mousques J, Renaud T, Scemama O (2010) Is the “practice style” hypothesis relevant for general practitioners? An analysis of antibiotics prescription for acute rhinopharyngitis. Soc Sci Med 70(8):1176–1184
De Jong JD, Westert GP, Lagoe R, Groenewegen PP (2006) Variation in hospital length of stay: do physicians adapt their length of stay decisions to what is usual in the hospital where they work? Health Serv Res 41(2):374–394
Hjerpe P, Ohlsson H, Lindblad U, Bostrom KB, Merlo J (2011) Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database. Eur J Clin Pharmacol 67(4):415–423
De Jong JD, Groenewegen PP, Spreeuwenberg P, Westert GP, de Bakker DH (2009) Do decision support systems influence variation in prescription? BMC Health Serv Res 9:20
Groenewegen P, Westert G (2004) Is there a time trend in medical practice variations? A review of the literature and a critical analysis of theoretical approaches. J Public Health 12(3):229–236
Ohlsson H, Chaix B, Merlo J (2009) Therapeutic traditions, patient socio-economic characteristics and physicians’ early new drug prescribing—a multilevel analysis of rosuvastatin prescription in South Sweden. Eur J Clin Pharmacol 65(2):141–150
Dalemo S, Hjerpe P, Ohlsson H, Eggertsen R, Merlo J, Bostrom KB (2010) Variation in plasma calcium analysis in primary care in Sweden—a multilevel analysis. BMC Fam Pract 11:43
Acknowledgements
We would like to thank the staff of LINH for their help in the data extraction and interpretation. This work was supported by the Dutch Ministry of Health.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ohlsson, H., Vervloet, M. & van Dijk, L. Practice variation in a longitudinal perspective: a multilevel analysis of the prescription of simvastatin in general practices between 2003 and 2009. Eur J Clin Pharmacol 67, 1205–1211 (2011). https://doi.org/10.1007/s00228-011-1082-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1082-8